Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy

Journal of Addictive Diseases

Volumn 30, Issue 4, 2011, Pages 318-322

  Newman, Robert G ^a   Gevertz, Susan G ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b Westchester County Health Care Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NALOXONE;

DRUG EFFICACY; HUMAN; MAINTENANCE THERAPY; METHADONE TREATMENT; OPIATE ADDICTION; PREGNANCY; PREGNANT WOMAN; REVIEW; SUBSTANCE ABUSE;

BUPRENORPHINE; FEMALE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84855757345     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.609806     Document Type: Review

References (25)

1. Committee on Health Care forUnderservedWomen. Substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist. Am J Obstet Gynecol 2011; 117:200-1.
2. Cooper JR, Altman F, Brown BS, Czechowicz D. Research on the treatment of narcotic addiction: state of the art. U.S. Department of Health and Human Services (ADM) 83-1281. Rockville, MD: National Institute on Drug Abuse; 1983.
3. Institute of Medicine. Federal regulation of methadone treatment. In: Rettig RA, Yarmolinsky A, eds. Washington, DC: National Academy Press; 1995:120-50.
4. National Institute on Drug Abuse. NIH panel calls for expanded methadone treatment for heroin addiction. NIDA Notes 1997; 12(6). Available at: http://archives.drugabuse.gov/NIDA Notes/NNVol12N6/NIHPanel.html
5. Office of National Drug Control Policy. Drug policy information clearinghouse fact sheet: Methadone. Washington, DC: Office of National Drug Control Policy, 2000.
6. WHO, Geneva, Switzerland 2004. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC) and Joint United Nations Programme on HIV/AIDS (UNAIDS) Position Paper: Substitution Maintenance Therapy in HIV/AIDS Prevention and Management of Opioid Dependence. http://www.unodc.org/documents/ hiv-aids/Position%20Paper% 20sub.%20maint.%20therapy.pdf. Accessed February 2, 2011.
7. World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. http://www.who.int/substance abuse/ publications/opioid dependence guidelines.pdf. Accessed February 2, 2011.
8. Code of Federal Regulations. Federal Opioid Treatment Standards. 42 CFR 8.12(f)(3).
9. Substance Abuse and Mental Health Services Administration. Methadone treatment for pregnant women. DHHS publication No. [SMA] 06-4124. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2006.
10. Substance Abuse and Mental Health Services Administration. Buprenorphine: about buprenorphine therapy. http://buprenorphine.samhsa.gov/about.html. Accessed February 2, 2011.
11. Montoya ID, Gorelick DA, Preston KL, et al. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther 2004; 75:34-48.
12. Substance Abuse and Mental Health Services Administration. Buprenorphine: drug Addiction Treatment Act of 2000. http://buprenorphine.samhsa.gov/ titlexxxv.html. Accessed February 2, 2011.
13. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Eng J Med 2010; 363:2320-31.
14. Hallfors D, Cho H, Sanchez V, Khatapoush S, Kim HM, Bauer D. Efficacy vs effectiveness trial results of an indicated "model" substance abuse program: implications for public health. Am J Pub Health 2006; 96:2254-9. (Pubitemid 44865121)
15. Cohn M. Bupe better than methadone for addicted moms. Baltimore Sun, December 9, 2010. http://weblogs.baltimoresun.com / health / 2010 / 12 / bupe better than methadone for.html. Accessed February 3, 2011.
16. Johns Hopkins Medical Institutions. Buprenorphine is better than methadone for opioid dependence in pregnant women, study shows. EurekAlert, December 9, 2010. http://www.eurekalert.org/pub releases/2010-12/jhmi-bib120910. php. Accessed February 3, 2011.
17. Stovell K, Knopf A, Enos G, Devaux D, Cohen DeAngelis I (eds). Buprenorphine produces less withdrawal in babies than methadone. Alc Drug Abuse Wkly 2010; 22(47):1-3.
18. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Ab Treatm 2008; 35:245-59.
19. Saiki T, Lee S, Hannan S. Neonatal abstinence syndrome: postnatal ward versus neonatal unit management. Eur J Pediatr 2010; 169:95-8.
20. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ 2001; 165:1339-41. (Pubitemid 33044065)
21. National Institute on Drug Addiction (NIDA). Buprenorphine treatment in pregnancy: less distressto babies. http://www.nih.gov/news/health/dec2010/ nida09.htm. Accessed February 3, 2011.
22. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal Abstinence Syndrome after methadone or buprenorphine exposure.NEng JMed 2010; 363:2320-31. Supplementary Appendix Table 2, page 1.
23. Gee B. New treatment may help addicted newborns. The Tennessean, December 27, 2010, p 14.
24. About Gateway health plan. http://www.gatewayhealthplan.com/aboutus/ default.aspx. Accessed January 26, 2011.
25. Mamula KB. Health insurer pushes to improve care for pregnant addicts. Pittsburgh Business Times, January 14-20, 2011, p. 3.